RA Capital Investments

RA Capital has invested in 371 companies and its latest investment was Vivace on Mar 11, 2025

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

Vivace is a pharmaceutical company that develops and commercializes small molecule drugs for the treatment of cancer diseases.
$35M
Mar 11, 2025
-
Curevo is a Washington-based biotechnology company that researches and develops vaccines for the treatment of infectious diseases.
$110M
Mar 05, 2025
-
NanoMosaic is a Massachusetts-based biotechnology company that designs and develops biomarker detection and analysis tools for researchers.
$1M
Feb 19, 2025
-
Vaxess is a Massachusetts-based life sciences company that designs, develops and supplies shelf-stable MIMIX skin patches for the pharmaceutical industry.
$8.4M
Feb 13, 2025
-
$90M
Feb 13, 2025
-

Frequently Asked Questions about RA Capital

  1. What is RA Capital investing in?

    RA Capital has invested in 371 companies including Vivace, Curevo and NanoMosaic
  2. What company did RA Capital invest in?

    RA Capital invested in a total 371 companies including Vivace, Curevo and NanoMosaic
  1. What are the top 5 investments by RA Capital?

    The top companies in which RA Capital invested are Vivace, Curevo, NanoMosaic, Vaxess and Bambusa Therapeutics